Use Able AI chat for product recommendations

PI3 Kinase p85 Alpha Polyclonal antibody

P85a; PIK3R1 Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

Human and More (3)

Applications

WB, IF, ELISA

GRB1, p85, p85 ALPHA, PI3 kinase subunit p85 alpha, PI3K regulatory subunit alpha, PIK3R1

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for P85a; PIK3R1 in ?

Tested Applications

Positive WB detected inA549 cells, HEK-293 cells, HepG2 cells, Jurkat cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:5000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

30092-1-AP targets P85a; PIK3R1 in WB, IF, ELISA applications and shows reactivity with Human samples.

Tested Reactivity Human
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

Peptide

Predict reactive species
Full Name phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
Calculated Molecular Weight 85 kDa
Observed Molecular Weight 85 kDa
GenBank Accession NumberBC030815
Gene Symbol PI3 Kinase p85 Alpha
Gene ID (NCBI) 5295
RRIDAB_3086227
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDP27986
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Protocols

Product Specific Protocols
WB protocol for P85a; PIK3R1 antibody 30092-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The PI3 Kinase p85 Alpha polyclonal antibody (Cat# 30092-1-AP) has 11 total citations spanning journals including Cell Death & Disease, International Journal of Biological Sciences, Journal of Ethnopharmacology, Biomaterials Advances, International Immunopharmacology, Frontiers in Pharmacology, Bioorganic Chemistry, Scientific Reports, Acta Biochimica et Biophysica Sinica, and Frontiers in Oncology. Research fields encompass cancer biology (lung, ovarian, breast, esophageal, nasopharyngeal carcinomas), PI3K/AKT signaling, metabolic regulation, and immune-related mechanisms.

SpeciesApplicationTitle

Cell Death Dis

The dual mechanism of m6A demethylase ALKBH5 in regulating energy metabolism during exposure to MC-LR

Authors - Xiaoya Sun
humanWB,IF

Int J Biol Sci

BRD7 Inhibited Immune Escape in Nasopharyngeal Carcinoma via Inhibiting PD-L1 Expression

Authors - Yilin Guo
humanWB

J Ethnopharmacol

Cornus officinalis loganin attenuates acute lung injury in mice via regulating the PI3K/AKT/NLRP3 axis

Authors - Yiran Liu
human, mouseWB

Biomater Adv

Rehmannia-derived nanovesicles hijack the cell cycle to suppress oral squamous cell carcinoma via PI3K-AKT pathway blockade.

Authors - Liyu Huang

Int Immunopharmacol

Vitamin D against diabetic adipose tissue inflammation through SHP-1/STAT3 pathway

Authors - Xiaonuo Wei
humanWB

Front Pharmacol

Immune-related gene risk model establishment and role of key gene FUCA1 in malignant pleural mesothelioma

Authors - Lin Shi
Loading...
||
New chat

Able™

正在加载,请稍候...